Specifically, we sought to test the hypothesis that a matrix enriched in collagen and fibronectin/vitronectin, mimicking aspects of the remodeled epithelium that is observed natively during tumor progression, would stimulate breast cancer cells relative to a matrix rich in laminin, mimicking aspects of a healthy mammary epithelium. The gene discussed is VTN; the disease is breast cancer.